BIOZONE PHARMACEUTICALS, INC.

New Filing
CIK: 0001412486·Pharmaceuticals·NEVADA·Filed: May 29, 2012
Total Offering

$250,000

Amount Sold

$250,000

Investors

1

First Sale

Apr 18, 2012

Offering Details

Type
Other: Convertible Promissory Note
Exemptions
Rule 506
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Elliot M Maza
Roberto Prego-Novo
Brian Keller
Christian Oertle

Company

BIOZONE PHARMACEUTICALS, INC.

550 SYLVAN AVENUE, SUITE 101

ENGLEWOOD CLIFFS, NJ, 07632

201 608 5101

SEC Filing

0001521536-12-000483

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
BIOZONE PHARMACEUTICALS, INC. Form D Filing — $250,000 | FilingFlow